LYMPHATIC SYSTEMS QUESTIONS AND ANSWERS
NEW UPDATE 2026-2027 GRADED A+
49 QUESTIONS
TABLE OF CONTENTS
# TOPIC
1 Differentiate the molecular and cellular mechanisms underlying cardiovascular, hematologic, and
lymphatic disorders to predict clinical manifestations and complications
2 Interpret advanced diagnostic data (hemodynamic parameters, coagulation assays, peripheral blood
findings) to construct prioritized differential diagnoses
3 Evaluate the appropriateness and physiological rationale of contemporary therapeutic interventions for
complex cardiovascular and hematologic conditions
4 NU 545 Unit 4
5 Cardiovascular
6 Hematologic
7 & Lymphatic Systems Questions and Answers New Update 2026
8 2027 Graded A+
9 Foundations of Advanced Pathophysiology: Cardiovascular, Hematologic, & Lymphatic Systems
10 Applied Advanced Pathophysiology: Cardiovascular, Hematologic, & Lymphatic Systems
11 Advanced Advanced Pathophysiology: Cardiovascular, Hematologic, & Lymphatic Systems
12 Advanced Pathophysiology: Cardiovascular, Hematologic, & Lymphatic Systems Review
ABSTRACT
Page 1
,This study document brings together 49 carefully worded exam questions drawn from NU 545 Unit
4: Cardiovascular, Hematologic, & Lymphatic Systems Questions and Answers New Update
2026-2027 Graded A+, with the strongest emphasis placed on Differentiate the molecular and
cellular mechanisms underlying cardiovascular, hematologic, and lymphatic disorders to predict
clinical manifestations and complications, Interpret advanced diagnostic data (hemodynamic
parameters, coagulation assays, peripheral blood findings) to construct prioritized differential
diagnoses and Evaluate the appropriateness and physiological rationale of contemporary
therapeutic interventions for complex cardiovascular and hematologic conditions. Every item
follows the wording style and level of reasoning you meet in the real paper, and each one is paired
with a clear rationale so the correct choice is never a guess. Work through the set at your own
pace, mark the questions that slow you down, then come back to them until the reasoning feels
automatic. Learners who revise this way walk into the exam room recognising the pattern behind
the questions instead of meeting them for the first time. Keep going - steady, honest practice is
what turns a difficult paper into a comfortable pass.
Q1 DIFFERENTIATE THE MOLECULAR AND CELLULAR MECHANISMS UNDERLYING
CARDIOVASCULAR, HEMATOLOGIC, AND LYMPHATIC DISORDERS TO PREDICT CLINICAL
MANIFESTATIONS AND COMPLICATIONS
A patient with chronic heart failure has an echocardiogram showing a restrictive
filling pattern, elevated left atrial pressure, and preserved left ventricular ejection
fraction. Which pathophysiologic mechanism best explains these findings?
A. Impaired myocardial relaxation and increased ventricular stiffness CORRECT
B. Reduced myocardial contractility with eccentric hypertrophy
C. Increased afterload due to systemic vasoconstriction
D. Pericardial constriction limiting diastolic filling
RATIONALE: A restrictive filling pattern with preserved ejection fraction and elevated left atrial
pressure indicates diastolic dysfunction, primarily due to impaired relaxation and increased
ventricular stiffness (HFpEF). Reduced contractility (B) would decrease ejection fraction;
increased afterload (C) is a contributor but not the primary mechanism; pericardial constriction
(D) would show different hemodynamic features (e.g., ventricular interdependence).
Page 2
, Q2 DIFFERENTIATE THE MOLECULAR AND CELLULAR MECHANISMS UNDERLYING
CARDIOVASCULAR, HEMATOLOGIC, AND LYMPHATIC DISORDERS TO PREDICT CLINICAL
MANIFESTATIONS AND COMPLICATIONS
In a patient with suspected disseminated intravascular coagulation (DIC), which
laboratory pattern is most characteristic?
A. Prolonged PT and aPTT, elevated D-dimer, low platelet count CORRECT
B. Shortened PT and aPTT, elevated fibrinogen, normal platelet count
C. Prolonged bleeding time, normal PT/aPTT, increased factor VIII
D. Isolated prolonged aPTT, normal PT, decreased von Willebrand factor
RATIONALE: DIC involves widespread activation of coagulation, leading to consumption of
clotting factors and platelets, resulting in prolonged PT/aPTT, elevated D-dimer (from fibrinolysis),
and thrombocytopenia. Option B describes a hypercoagulable state; C is more consistent with a
platelet function defect; D suggests von Willebrand disease or isolated intrinsic pathway defect.
Q3 DIFFERENTIATE THE MOLECULAR AND CELLULAR MECHANISMS UNDERLYING
CARDIOVASCULAR, HEMATOLOGIC, AND LYMPHATIC DISORDERS TO PREDICT CLINICAL
MANIFESTATIONS AND COMPLICATIONS
Which lymphatic structure primarily drains lymph from the lower extremities and
abdominopelvic cavity into the venous system?
A. Right lymphatic duct
B. Thoracic duct CORRECT
C. Cisterna chyli
D. Subclavian vein directly
RATIONALE: The thoracic duct drains lymph from the lower body, abdomen, and left upper body
into the left subclavian vein. The right lymphatic duct (A) drains the right upper body; the cisterna
chyli (C) is a sac that receives lymph from the lower body but drains into the thoracic duct; the
subclavian vein (D) is the entry point, not the duct itself.
Page 3